Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SGRY Surgery Partners Inc
- Stocks
- Healthcare
- NASDAQ: SGRY
Price (delayed)
$23.94
Market cap
$3.07B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.53
Enterprise value
$6.66B
Surgery Partners is headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for
Highlights
The revenue has grown by 14% YoY
The gross profit has grown by 12% year-on-year
SGRY's debt is up by 22% YoY and by 4.4% QoQ
The net income has declined by 15% since the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.surgerypartners.com
Peers:
MD
Key stats
What are the main financial stats of SGRY
Market
Valuations
Earnings
Shares outstanding
128.16M
Market cap
$3.07B
Enterprise value
$6.66B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.76
Price to sales (P/S)
0.96
EV/EBIT
43.43
EV/EBITDA
19.14
EV/Sales
2.1
Revenue
$3.17B
Gross profit
$752.2M
Operating income
$317.4M
Net income
-$193.4M
EBIT
$153.4M
EBITDA
$348.1M
Free cash flow
$179.2M
Per share
Balance sheet
Liquidity
EPS
-$1.53
EPS diluted
-$1.53
Free cash flow per share
$1.42
Book value per share
$13.64
Revenue per share
$25.06
TBVPS
$21.94
Total assets
$7.95B
Total liabilities
$4.79B
Debt
$3.82B
Equity
$1.74B
Working capital
$505.2M
Debt to equity
2.2
Current ratio
1.89
Quick ratio
1.4
Net debt/EBITDA
10.33
Margins
Efficiency
Dividend
EBITDA margin
11%
Gross margin
23.7%
Net margin
-6.1%
Operating margin
10%
Return on assets
-2.5%
Return on equity
-10.5%
Return on invested capital
2.8%
Return on capital employed
2.1%
Return on sales
4.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SGRY stock price
How has the Surgery Partners stock price performed over time
Intraday
1.29%
1 week
8.03%
1 month
13.51%
1 year
-9.49%
YTD
13.08%
QTD
0.8%
Financial performance
How have Surgery Partners's revenue and profit performed over time
Revenue
$3.17B
Gross profit
$752.2M
Operating income
$317.4M
Net income
-$193.4M
Gross margin
23.7%
Net margin
-6.1%
Surgery Partners's operating margin has decreased by 22% YoY and by 7% QoQ
The net income has declined by 15% since the previous quarter
The revenue has grown by 14% YoY
SGRY's net margin is down by 13% QoQ
Price vs fundamentals
How does SGRY's price correlate with its fundamentals
Growth
What is Surgery Partners's growth rate over time
Valuation
What is Surgery Partners stock price valuation
P/E
N/A
P/B
1.76
P/S
0.96
EV/EBIT
43.43
EV/EBITDA
19.14
EV/Sales
2.1
SGRY's EPS is down by 15% from the previous quarter
The stock's price to book (P/B) is 54% less than its 5-year quarterly average of 3.8 but 3.5% more than its last 4 quarters average of 1.7
The equity has declined by 12% year-on-year and by 2.8% since the previous quarter
The P/S is 26% below the 5-year quarterly average of 1.3 and 13% below the last 4 quarters average of 1.1
The revenue has grown by 14% YoY
Efficiency
How efficient is Surgery Partners business performance
SGRY's ROIC is down by 33% YoY and by 13% from the previous quarter
SGRY's ROS is down by 32% YoY and by 11% from the previous quarter
Surgery Partners's ROE has decreased by 19% from the previous quarter
SGRY's return on assets is down by 14% since the previous quarter
Dividends
What is SGRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SGRY.
Financial health
How did Surgery Partners financials performed over time
The total assets is 66% greater than the total liabilities
Surgery Partners's total liabilities has increased by 22% YoY and by 2.1% QoQ
The total assets is up by 14% year-on-year
SGRY's debt is 120% higher than its equity
The debt to equity has grown by 38% YoY and by 7% from the previous quarter
SGRY's debt is up by 22% YoY and by 4.4% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.